Invadopodia and rolling-type motility are specific features of highly invasive p190bcr-abl leukemic cells

European Journal of Cell Biology

Volumn 91, Issue 11-12, 2012, Pages 978-987

  Daubon, Thomas ^a,b   Rochelle, Tristan ^c   Bourmeyster, Nicolas ^c   Génot, Elisabeth ^a,b,d  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSTITUT EUROPÉEN DE CHIMIE ET BIOLOGIE   (France)

^c CNRS   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Bcr Abl; Cytoskeleton; Guanine exchange factor; Invadopodia; Invasion; Leukemia; Matrix remodeling; Mobility; RhoGTPase

Indexed keywords

BCR ABL PROTEIN; COMPLEMENTARY DNA; F ACTIN; FIBRONECTIN; MATRIGEL; PROTEIN CDC42; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL MOTILITY; CHRONIC MYELOID LEUKEMIA; DRUG TARGETING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; LEUKEMIA; LEUKEMIA CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TIME LAPSE IMAGING;

ACTINS; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURFACE EXTENSIONS; FUSION PROTEINS, BCR-ABL; HUMANS; LYMPHOCYTES; NEOPLASM INVASIVENESS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RHOA GTP-BINDING PROTEIN;

EID: 84867400471     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2012.04.006     Document Type: Article

References (28)

1. Artym V.V., Zhang Y., Seillier-Moiseiwitsch F., Yamada K.M., Mueller S.C. Dynamic interactions of cortactin and membrane type1 matrix metalloprotease at invadopodia defining the stages of invadopodia formation and function. Cancer Res. 2006, 66:3034-3043.
2. Berdeaux R.L., Diaz B., Kim L., Martin G.S. Active Rho is localized to podosomes induced by oncogenic Src and is required for their assembly and function. J. Cell Biol. 2004, 166:317-323.
3. Bravo-Cordero J.J., Oser M., Chen X., Eddy R., Hodgson L., Condeelis J. A novel spatiotemporal RhoC activation pathway locally regulates cofilin activity at invadopodia. Curr. Biol. 2011, 21:635-644.
4. Buccione R., Orth J.D., McNiven M.A. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat. Rev. Mol. Cell Biol. 2004, 5:647-657.
5. Caligaris-Cappio F., Bergui L., Tesio L., Corbascio G., Tousco F., Marchisio P.C. Cytoskeleton organization is aberrantly rearranged in the cells of B chronic lymphocytic leukemia and hairy cell leukemia. Blood 1986, 67:233-239.
6. Chaigne-Delalande B., Deuve L., Reuzeau E., Basoni C., Lafarge D., Varon C., Tatin F., Anies G., Garand R., Kramer I., Genot E. RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells. Am. J. Pathol. 2006, 168:562-573.
7. Daubon T., Chasseriau J., El Ali J., Rivet A., Kitzis A., Constantin B., Bourmeyster N. Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs. Oncogene 2008, 27:2673-2685.
8. Destaing O., Saltel F., Gilquin A., Chabadel A., Khochbin S., Ory S., Jurdic P. A novel Rho-mDia2-HDAC6 pathway controls podosome patterning through microtubule acetylation in osteoclasts. J. Cell Sci. 2005, 118:2901-2911.
9. El-Sibai M., Pertz O., Pang H., Yip S.C., Lorenz M., Symons M., Condeelis J.S., Hahn K.M., Backer J.M. RhoA/ROCK-mediated switching between Cdc42- and Rac1-dependent protrusion in MTLn3 carcinoma cells. Exp. Cell Res. 2008, 314:1540-1552.
10. Friedl P. Prespecification and plasticity: shifting mechanisms of cell migration. Curr. Opin. Cell Biol. 2004, 16:14-23.
11. Harnois T., Constantin B., Rioux A., Grenioux E., Kitzis A., Bourmeyster N. Differential interaction and activation of Rho family GTPases by p210bcr-abl andp190bcr-abl. Oncogene 2003, 22:6445-6454.
12. Ilaria R.L., Van Etten R.A. P210 and P190(BCR/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J. Biol. Chem. 1996, 271:31704-31710.
13. Li Y., Clough N., Sun X., Yu W., Abbott B.L., Hogan C.J., Dai Z. Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway. J. Cell Sci. 2007, 120:1436-1446.
14. Lizarraga F., Poincloux R., Romao M., Montagnac G., Le Dez G., Bonne I., Rigaill G., Raposo G., Chavrier P. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells. Cancer Res. 2009, 69:2792-2800.
15. Lugo T.G., Pendergast A.M., Muller A.J., Witte O.N. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990, 247:1079-1082.
16. Marchisio P.C., Bergui L., Corbascio G.C., Cremona O., D'Urso N., Schena M., Tesio L., Caligaris-Cappio F. Vinculin, talin, and integrins are localized at specific adhesion sites of malignant B lymphocytes. Blood 1988, 72:830-833.
17. Moorman J.P., Luu D., Wickham J., Bobak D.A., Hahn C.S. A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival. Oncogene 1999, 18:47-57.
18. Nakahara H., Otani T., Sasaki T., Miura Y., Takai Y., Kogo M. Involvement of Cdc42 and Rac small G proteins in invadopodia formation of RPMI7951 cells. Genes Cells 2003, 8:1019-1027.
19. Nobes C., Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 1999, 144:1235-1244.
20. Nourshargh S., Hordijk P.L., Sixt M. Breaching multiple barriers: leukocyte motility through venular walls and the interstitium. Nat. Rev. Mol. Cell Biol. 2010, 11:366-378.
21. Redondo-Munoz J., Escobar-Diaz E., Samaniego R., Terol M.J., Garcia-Marco J.A., Garcia-Pardo A. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration. Blood 2006, 108:3143-3151.
22. Ridley A.J. Life at the leading edge. Cell 2011, 145:1012-1022.
23. Sakurai-Yageta M., Recchi C., Le Dez G., Sibarita J.B., Daviet L., Camonis J., D'Souza-Schorey C., Chavrier P. The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA. J. Cell Biol. 2008, 181:985-998.
24. Salgia R., Li J.L., Ewaniuk D.S., Pear W., Pisick E., Burky S.A., Ernst T., Sattler M., Chen L.B., Griffin J.D. BCR/ABL induces multiple abnormalities of cytoskeletal function. J. Clin. Invest. 1997, 100:46-57.
25. Salgia R., Quackenbush E., Lin J., Souchkova N., Sattler N., Ewaniuk D.S., Klucher K.M., Daley G.Q., Kraeft S.K., Sackstein R., Alyea E.P., von Andrian U.H., Chen L.B., Gutierrez-Ramos J.C., Pendergast A.M., Griffin J.D. The BCR/ABL oncogene alters the chemotactic response to stromal-derived factor-1alpha. Blood 1999, 94:4233-4246.
26. Sander E.E., ten Klooster J.P., van Delft S., van der Kammen R.A., Collard J.G. Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol. 1999, 147:1009-1022.
27. Seals D.F., Azucena E.F., Pass I., Tesfay L., Gordon R., Woodrow M., Resau J.H., Courtneidge S.A. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell 2005, 7:155-165.
28. Smith-Pearson P.S., Greuber E.K., Yogalingam G., Pendergast A.M. Abl kinases are required for invadopodia formation and chemokine-induced invasion. J. Biol. Chem. 2010, 285:40201-40211.